NASDAQ:IOVA
Iovance Biotherapeutics, Inc.
- Stock
Last Close
9.43
26/07 20:00
Market Cap
2.18B
Beta: 0.20
Volume Today
6.52M
Avg: 3.51M
PE Ratio
−4.56
PFCF: −7.39
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 5.19M - | |||||||||||
average payables | 755.62K - | 830.69K 9.93% | 1.10M 32.81% | 910.50K 17.47% | 1.05M 15.05% | 1.99M 89.55% | 9.15M 360.99% | 14.54M 58.86% | 20.45M 40.61% | 26.99M 32.01% | 29.86M 10.64% | |
average receivables | 75.50K - | |||||||||||
book value per share | 1.80 - | 1.79 0.47% | 2.34 30.51% | 3.02 28.94% | 2.23 26.17% | 4.79 114.92% | 2.40 49.83% | 4.75 97.41% | 4.05 14.63% | 3.14 22.58% | 2.49 20.75% | |
capex per share | -0.00 - | -0.06 4,796.00% | -0.03 59.61% | -0.03 6.93% | -0.02 42.75% | -0.01 21.84% | -0.06 351.73% | -0.34 508.16% | -0.24 27.61% | -0.13 47.64% | -0.09 26.08% | |
capex to depreciation | -1.79 - | -18.05 906.62% | -1.14 93.66% | -1.56 35.93% | -1.08 30.57% | -1.25 16.05% | -5.92 372.18% | -41.04 593.67% | -2.69 93.45% | -0.97 64.04% | -1.03 6.98% | |
capex to operating cash flow | 0.00 - | 0.18 5,215.49% | 0.06 66.28% | 0.05 25.13% | 0.01 71.95% | 0.01 9.41% | 0.04 267.92% | 0.23 423.96% | 0.16 27.73% | 0.07 57.68% | 0.06 11.70% | |
capex to revenue | -18.75 - | |||||||||||
cash per share | 2.02 - | 1.80 10.80% | 4.36 142.74% | 4.09 6.18% | 2.23 45.56% | 4.82 116.15% | 2.47 48.72% | 4.55 84.28% | 3.29 27.75% | 2.96 9.89% | 1.19 59.83% | |
days of inventory on hand | 352.00 - | |||||||||||
days payables outstanding | 32.38 - | 48.81 50.74% | 1.12K - | |||||||||
days sales outstanding | 46.35 - | |||||||||||
debt to assets | 0.03 - | 0.07 101.47% | 0.09 36.89% | 0.15 58.81% | 0.10 34.35% | |||||||
debt to equity | 0.04 - | 0.08 104.57% | 0.12 46.23% | 0.19 68.78% | 0.13 34.06% | |||||||
dividend yield | 0.13 - | |||||||||||
earnings yield | -0.25 - | -0.06 75.28% | -0.08 31.82% | -0.14 70.68% | -0.18 28.09% | -0.14 18.62% | -0.05 62.13% | -0.04 26.26% | -0.11 179.27% | -0.38 242.28% | -0.23 39.38% | |
enterprise value | 82.83M - | 151.73M 83.17% | 239.15M 57.61% | 217.64M 8.99% | 376.56M 73.02% | 778.75M 106.80% | 3.44B 341.62% | 6.40B 86.14% | 2.92B 54.36% | 870.38M 70.21% | 1.87B 115.03% | |
enterprise value over ebitda | -3.66 - | -12.69 246.87% | -8.58 32.38% | -4.06 52.73% | -4.05 0.08% | -6.07 49.76% | -16.62 173.80% | -24.55 47.65% | -8.53 65.27% | -2.18 74.41% | -4.06 86.23% | |
ev to operating cash flow | -22.62 - | -17.58 22.30% | -13.01 25.97% | -6.66 48.79% | -4.78 28.19% | -7.69 60.77% | -21.64 181.42% | -31.21 44.17% | -12.82 58.92% | -2.97 76.81% | -5.17 73.99% | |
ev to sales | 1.57K - | |||||||||||
free cash flow per share | -0.38 - | -0.41 8.72% | -0.44 7.43% | -0.62 40.71% | -1.22 97.57% | -1.05 13.83% | -1.33 26.62% | -1.82 36.60% | -1.73 4.98% | -1.97 13.62% | -1.63 16.93% | |
free cash flow yield | -0.04 - | -0.05 45.05% | -0.06 9.51% | -0.09 56.30% | -0.15 71.64% | -0.12 22.11% | -0.05 59.52% | -0.04 18.51% | -0.09 130.95% | -0.31 239.43% | -0.20 34.71% | |
graham net net | 1.78 - | 1.73 2.90% | 4.33 149.95% | 4.00 7.46% | 2.08 48.13% | 4.67 124.70% | 2.10 54.94% | 3.74 77.98% | 2.27 39.24% | 1.93 15.06% | 0.38 80.30% | |
graham number | 10.27 - | 4.41 57.06% | 5.73 29.91% | 8.06 40.76% | 8.41 4.34% | 11.70 39.10% | 9.02 22.91% | 14.09 56.22% | 13.96 0.96% | 13.15 5.82% | 10.28 21.82% | |
income quality | 0.14 - | 0.72 397.18% | 0.66 7.36% | 0.62 7.06% | 0.85 38.43% | 0.82 4.17% | 0.80 1.83% | 0.79 1.74% | 0.67 15.72% | 0.74 11.03% | 0.81 10.19% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.29 Infinity% | |
interest coverage | -50.91 - | -2.13K 4,078.57% | -139.30 93.45% | -133.63 - | ||||||||
interest debt per share | 0.05 - | 0.00 99.50% | 0.00 1,888.06% | 0.09 - | 0.37 303.85% | 0.47 24.83% | 0.63 34.69% | 0.32 49.30% | ||||
inventory turnover | 1.04 - | |||||||||||
invested capital | 0.04 - | 0.08 104.57% | 0.12 46.23% | 0.19 68.78% | 0.13 34.06% | |||||||
market cap | 102.51M - | 196.64M 91.83% | 342.85M 74.35% | 384.11M 12.04% | 521.94M 35.88% | 860.90M 64.94% | 3.44B 299.77% | 6.42B 86.46% | 2.93B 54.36% | 1.02B 65.25% | 1.91B 87.84% | |
net current asset value | 17.58M - | 43.31M 146.44% | 102.35M 136.29% | 164.54M 60.77% | 139.40M 15.28% | 460.75M 230.53% | 266.85M 42.08% | 524.14M 96.42% | 352.28M 32.79% | 307.50M 12.71% | 112.11M 63.54% | |
net debt to ebitda | 0.87 - | 3.76 332.31% | 3.72 0.94% | 3.10 16.62% | 1.57 49.57% | 0.64 59.08% | 0.01 98.14% | 0.06 403.44% | 0.02 67.47% | 0.37 1,789.26% | 0.09 76.46% | |
net income per share | -2.60 - | -0.48 81.47% | -0.62 29.31% | -0.96 53.66% | -1.41 47.44% | -1.27 9.97% | -1.50 18.43% | -1.86 23.62% | -2.14 14.90% | -2.45 14.57% | -1.89 22.87% | |
operating cash flow per share | -0.38 - | -0.35 7.89% | -0.41 19.79% | -0.59 42.81% | -1.21 104.10% | -1.04 13.73% | -1.28 22.78% | -1.48 16.07% | -1.49 0.18% | -1.84 23.72% | -1.54 16.29% | |
payables turnover | 11.27 - | 7.48 33.66% | 0.32 - | |||||||||
receivables turnover | 7.87 - | |||||||||||
research and ddevelopement to revenue | 289.38 - | |||||||||||
return on tangible assets | -1.28 - | -0.26 79.74% | -0.26 1.17% | -0.31 17.54% | -0.59 92.55% | -0.26 56.62% | -0.54 111.18% | -0.33 38.33% | -0.42 25.99% | -0.59 39.25% | -0.81 37.21% | |
revenue per share | 0.01 - | |||||||||||
roe | -1.44 - | -0.27 81.39% | -0.27 0.92% | -0.32 19.17% | -0.63 99.70% | -0.27 58.11% | -0.63 136.05% | -0.39 37.38% | -0.53 34.59% | -0.78 47.99% | -0.76 2.67% | |
roic | -1.31 - | -0.27 79.48% | -0.26 3.85% | -0.32 22.18% | -0.63 100.32% | -0.29 54.81% | -0.61 113.08% | -0.34 43.85% | -0.43 25.82% | -0.58 34.20% | -0.62 7.89% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 1.80 - | 1.79 0.47% | 2.34 30.51% | 3.02 28.94% | 2.23 26.17% | 4.79 114.92% | 2.40 49.83% | 4.75 97.41% | 4.05 14.63% | 3.14 22.58% | 2.49 20.75% | |
stock based compensation to revenue | 52.67 - | |||||||||||
tangible asset value | 17.60M - | 44.85M 154.75% | 104.02M 131.96% | 166.92M 60.46% | 145.48M 12.84% | 466.19M 220.45% | 298.97M 35.87% | 656.50M 119.59% | 621.66M 5.31% | 499.64M 19.63% | 355.36M 28.88% | |
tangible book value per share | 1.80 - | 1.79 0.47% | 2.34 30.51% | 3.02 28.94% | 2.23 26.17% | 4.79 114.92% | 2.40 49.83% | 4.75 97.41% | 4.05 14.63% | 3.14 22.58% | 1.51 51.83% | |
working capital | 17.58M - | 43.31M 146.44% | 102.35M 136.29% | 164.54M 60.77% | 139.40M 15.28% | 460.98M 230.69% | 273.45M 40.68% | 581.23M 112.56% | 418.76M 27.95% | 380.36M 9.17% | 197.54M 48.06% |
All numbers in USD (except ratios and percentages)